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ABSTRACT 
 
 
New techniques for biological optical imaging are of great interest for the detection and 
visualization of processes and disease in both clinical and research areas.  One major 
advancement has been the use of far red and near infrared (NIR) light, as it has the ability 
to penetrate tissues deeper than other parts of the spectrum which are readily scatter and 
absorbed by the surroundings.  In order to improve the signal to noise ratio and resolution 
of optical images, contrast agents are used.  Fluorescent markers can be modified to 
attach to specific molecular targets, creating small molecular probes.  These targets can 
be disease sites, or biological molecules which play a major role in processes such as 
tumor growth.  It was our goal to create a new novel fluorescent probe, consisting of a 
cyanine based far red to NIR marker, and an n-hydroxysuccinimide (NHS) derivative to 
act as a linker, which could then bind with biological species containing primary amides 
such as proteins and antibodies, in this model system bovine serum albumin (BSA).  The 
dye, a modified pentamethine carbocyanine, was synthesized according to Shao, et al.,
1
 
and was chosen for its previous use for in vivo visualization and preferred spectral 
properties, as well as its ability to incorporate different functionalities.  The linker was an 
azide functionalized NHS derivative chosen for its crosslinking ability with species 
containing primary amides.  Azide and alkyne functionality were of great interest due to 
their reactivity in [2+3] dipolar cycloaddition click type reactions, which was used to 
attach an azide on the NHS derivative and an alkyne on the dye.  This species was then 
bound to protein, BSA, successfully through this NHS moiety. 
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CHAPTER ONE 
 
INTRODUCTION 
 
 
Background Information 
 
 
Optical imaging is of great significance to the biological imaging community for its 
ability to provide high spacial resolution of deep tissues without patient discomfort or the 
use of ionizing radiation
2
.  Imaging is often accompanied by the use of contrast agents 
which highlight desired areas
3
.  There is a particular interest in the development of new 
targeted contrast agents which are specialized to accumulate at specific sites
4,5
.  This 
provides a better signal to noise ratio and better visualization
2
.  It was our goal to 
investigate and design a new, specialized fluorescent probe which would target proteins 
or antibodies for use in optical imaging.   
 
Medical imaging is widely relied on for clinical and research purposes, such as the 
diagnosis of disease and the investigation of biological processes
6, 7
.  There are several 
types of imaging, the most popular being ultrasound sonography, x-ray computed 
tomography (CT scan), magnetic resonance imaging (MRI), and optical imaging.  Each 
has its strengths and weaknesses depending on the area, extent, and precision of  
visualization required
3, 8
.  
 
Ultrasound, as the name implies, uses sound waves which travel through the tissue and 
the subsequent echoes are recorded
9
.  This technique is safe, provides real time 
  2 
visualization, and instrumentation is portable.  However, ultrasound is severely limited by 
penetration depth, resolution, and by areas which contain air or are surrounded by bone, 
such as the gastrointestinal tract and the chest cavity
10, 11
.  Today, this presents a new 
problem of imaging the obese population
12
.  In addition, soft tissues cannot always be 
clearly differentiated
9
.  CT scans use a series of x-rays around a single axis of rotation 
and relies on differences in x-ray attenuation, or loss of signal, to differentiate between 
soft tissues and bone.  CT scans use ionizing radiation, which can cause long term side 
effects such as cancers
13, 14
.  It also is difficult to distinguish between different soft tissues 
and is most commonly used for structural imaging, such as bone and vascular systems
6
.  
MRI uses a pulsing strong magnetic field and relies on differences in the relaxation times 
of biological molecules to create an image of soft tissues
15
.  The strong magnetic field 
can potentially interact with any implant or foreign metal in the body.  It also can be quite 
uncomfortable for patients
6, 15
.  Optical imaging uses light in the ultraviolet, visible, or 
near infrared regions of the spectrum and relies on differences in the spectral properties 
of biological species to compose an image
7
.  This type of imaging is of great interest as it 
is nontoxic and can provide deeper tissue imaging with enhanced spacial resolution
1, 2
.   
 
Often, to better differentiate between different biological species, contrast agents are 
used.  Contrast agents highlight areas of interest providing better visualization
3
.  
Ultrasound uses microbubbles, which are micron sized lipid or protein shells filled with 
gas which have a high echogenicity.  This can be injected intravenously to monitor blood 
flow and perfusion in organs
16
.  CT scans can use iodine or barium based markers, 
  3 
depending on the area of interest, which can be administered orally, rectally, or 
intravenously
3
.  Areas containing the agent have greater attenuation which provides 
“dark” areas on the resulting image13.  MRI uses gadolinium contrast agents which are 
paramagnetic and react to strongly to the magnetic field providing intense signals
17
.  
Optical imaging uses fluorescent dyes which absorb and emit light to produce a stronger 
signal at areas of interest
4
.  All of these techniques provide a better signal to background 
ratio.  
 
In many cases, these contrast agents come with their own side effects which can be quite 
serious.  Microbubbles used in ultrasound are fairly harmless, however if they rupture, 
they can rupture small vascular systems in the area
10, 16, 18
.  Iodine based contrast agents 
used in CT scans are known to cause allergic reactions and renal problems including 
kidney failure and death
14, 19, 20
.  Gadolinium, used in MRI, is a heavy metal which, when 
unbound, is toxic.  These agents rely on strong chelation to maintain limited toxicity, 
however ions may leach out causing nephrogenic systemic fibrosis which can lead to 
renal failure and the hardening of the lungs and heart
15,17
.  In optical imaging indocyanine 
green (ICG) has been the industry standard for more than 50 years with limited toxicity 
reported
2
.  Although this dye has proved its worth to the optical imaging community, 
there is an interest for new designer dyes which provide nontoxic, targeted visualization 
of specific molecular species
5
.   
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Motivation 
 
 
Optical imaging is of particular interest because of its nontoxic nature
7
.  Using light in the 
ultraviolet or visible range has stringent depth restrictions, with maximum penetration of 
up to a few millimeters due to strong scatter and absorption from biological species.  
There is, however, an optical or therapeutic window in tissues where deeper penetration 
is possible.  Between 600-1000 nanometers, penetration is increased due to a decrease in 
absorption and scatter from abundant species such as water and hemoglobin
2, 4, 5
.  Using 
agents which absorb and emit in this region allows for increases up to several 
centimeters.  If more photons are able to penetrate through to the target and then make it 
back to the detector without being scattered or reabsorbed then a stronger signal and 
better visualization is achieved and a lower concentration can be used to decrease risks of 
side effects, such as allergic reactions
2, 5
.   
 
Indocyanine green has been in use for more than 50 years.  It has little reported toxicity 
and its absorption and emission are within the optimal range for minimized background 
absorbance
21
.  Although it is useful for some applications, there is a desire for more 
exotic, specialized dyes which have tuned spectral properties and can be targeted to a 
specific molecular species
5
.  Binding with a species known to accumulate at the site of 
interest provides an increase in contrast in the resulting image.  Targeting can be 
achieved through the incorporation of moieties which are reactive with those present on 
the species of interest
1, 4, 5
.  
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Research Goals and Approach 
 
 
It was our goal to create a new fluorescent probe, which would absorb and emit within 
the optical window and provide targeted optical visualization of proteins which are often 
overexpressed at the surface of tumors.  We first needed to investigate an appropriate dye 
which provided a strong signal within the optical window at low toxicities.  Then we 
needed to incorporate a protein specific targeting moiety which would provide a means 
for biological conjugation.  Finally we needed to synthesize and conjugate the probe to a 
model protein, bovine serum albumin (BSA) in this system,  to ensure that binding can 
indeed occur
5, 22
.   
 
When looking for a potential dye, it was noted that carbocynanine dyes have been widely 
investigated as contrast agents in NIR in vivo imaging
1, 24
.  Cyanine derivatives are 
known to absorb and emit between 500-900nm depending on the length of the methanine 
bridge, the heterocyclic nuclei, as well as any species bound to the main scaffold
23-25,
 
25
.  
Increasing the length and conjugation of the bridge increases the absorption wavelength.  
However this also increases reactivity, subsequently lowering the stability
26
.  Indocyanine 
green is a cyanine-7 (Cy7) derivative with 7 carbons in this methanine bridge
23
.   
 
The particular cyanine derivative we are interested in is a cyanine-5 (Cy5) dye is known 
to absorb and emit at 642 and 658nm, which is within the optical window.  It has also 
been shown to incorporate three different functionalities, two of which are commonly 
  6 
used in click type reactions
1
.  Azide and alkyne functionalities, in the presence of sodium 
ascorbate and copper (II) sulfate, readily take part in Hüisgen cycloadditions
27
.  This 
provides a simple means of attachment for a bio reactive moiety.   
 
The objective was to link a carbocynanine Cy5 dye to a protein or antibody.  N-
hydroxysuccinimide (NHS), which is a common cross linker used in standard methods 
for dye attachment to protein was investigated and modified with an azidopropane 
derivative
28
.  This azide functionality made it “click-able” to the alkyne containing dye29.  
With this lysine reactive moiety, the dye should be targeted toward proteins or antibodies.  
In this case, BSA was used as a model system to determine if the modified NHS would 
bind. 
 
An appropriate dye with the desired properties was determined along with a means for 
the attachment of this dye to a biological molecule.  This was accomplished through a 
pentamethine cyanine dye containing an alkyne moiety which has been attached to an 
NHS based linker through click chemistry methods, resulting in a stable 1, 2, 3 triazole.  
The final molecular probe was shown to maintain its spectral characteristics in 
preliminary results when bound to a protein, BSA.    
 
 
Thesis Outline 
  
 
In this thesis, a literary review is presented as a justification for the pursuit of a 
fluorescent dye which is able to conjugate and act as a targeted probe.  This highlights 
  7 
medical imaging and contrast agents, desired spectral properties which go into the choice 
of a fluorescent dye, methods used for targeting, and an overview of the system of study.  
This is followed by an experimental section where procedure for the synthesis, assembly 
of the molecular probe, and bioconjugation will be discussed.  The results and 
conclusions discuss the findings of the research which is followed by potential future 
work to advance the project.   
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CHAPTER TWO 
 
LITERATURE REVIEW 
 
 
Imaging 
 
 
Biological imaging is widely used in both clinical and research fields to reveal, diagnose, 
and examine disease.  It provides a means for early detection through noninvasive 
visualization of specific molecular targets
8, 30
.  The most commonly used types of 
imaging include ultrasound sonography, computed tomography (CT), magnetic resonance 
imaging (MRI), and optical imaging
3, 6
.  All rely on the detection of differences in the 
composition of biological features to create an image.  This detection can be based on 
differences in echogenicity in the case of ultrasound, density as with CT scans, chemical 
composition as with MRI, or spectral properties in the case of optical imaging
2, 4, 14, 31, 
 
 
Sonography, or ultrasound, is one of the safest forms of medical imaging
6
.  Sound waves 
are introduced to the body and echoes are detected and used to create an image, much 
like a bat uses echolocation to gain awareness of its surroundings
11
.  From a cost 
standpoint, it is one of the least expensive types of visualization available.  However, 
ultrasound is severely limited by depth and the presence of bone and air in the system
12
.  
Areas surrounded by bone or filled with air cannot be clearly imaged using this 
technique, including the brain, chest cavity, gastrointestinal tract, and lungs
10, 11
.  With 
increasing obesity rates, penetration depth is becoming more of a concern, especially in 
pregnant women
12
.  Penetration depth can be increased by lowering the frequency; 
  9 
however this also lowers the resolution of the resulting image.  At higher frequencies, 
higher resolutions can be obtained, however this is accompanied by increases in 
attenuation (or loss of signal) and scatter, restricting penetration
31
.  .   
 
Computed tomography (CT) compiles a series of x-rays taken on a single axis of rotation 
to produce an image in nearly real time.  CT scans detect differences in density, making 
resolution between soft tissues low.  It is best suited for imaging of structural aspects 
such as bone, bowel, and vascular systems
6, 13
.  The major concern with CT scans is the 
dose of ionizing radiation the patient receives, which can be 30-400 times that of a single 
x-ray depending on the location and extent of visualization required.  It is estimated that 
as of 2007 as many as 0.7% of cancers in the United States are caused by CT imaging.  
With an increase in use and overuse, this number is expected to increase up to 2%
14, 32
.  
Half of the ionizing radiation an American sees in his or her lifetime is due to medical 
imaging
14
.  Another downfall with CT scan is patient movement which can blur the 
resulting image, requiring another scan
6, 32
.   
 
Magnetic resonance imaging (MRI) provides high resolution images in nearly real time 
with the use of a strong magnetic field.  Although it does not use ionizing radiation, this 
field can interact with implants, such as pacemakers, and foreign metal lodged in the 
body
15
.  This strong magnetic field is turned on and off in quick secession, measuring the 
relaxation times of different molecular species present.  The pulsing field can also cause 
peripheral nerve stimulation, where extremities may twitch or move
33
.  Like CT scans, 
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MRI images are also blurred by patient movement.  MRI can be quite uncomfortable for 
some patients.  Although open systems do exist, most are narrow cylinders which use a 
backboard to slide the patient inside, and often require restraining the head.  This 
confined space accompanied by restraint and very loud noises can be intolerable for even 
mildly claustrophobic patients
34
.  This is also limiting for obese patients who may be too 
wide or over the weight limit of the table
6, 35
.   
 
Optical imaging uses light in the ultraviolet (UV), visible, or near infrared (NIR) regions 
to distinguish between molecular species based on their spectral properties
2
.  This type of 
imaging is of great interest due to its nontoxic nature and its ability to produce 
visualization with high spacial resolution between soft tissues.  Light which enters the 
body is absorbed and scattered by abundant species such as water, blood, and skin
7
.  
There exists an optical window between 600-1000nm where maximum penetration is 
observed, this is seen in figure 1.  At wavelengths outside this region, scatter and 
absorption restricts penetration to only a few millimeters.  Light within the optical 
window can penetrate several centimeters.  This technology can also be adapted to be 
used with an endoscope for even deeper tissue imaging
2, 7
.   
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Figure 1: The optical window is clear by looking at the absorbance spectra for prevalent 
biomolecules: water, hemoglobin (Hb), oxygenated hemoglobin (HbO2), and melanin
36
. 
 
 
Contrast Agents 
 
 
Often to better distinguish between the background and the region of interest different 
contrast agents are used.  Contrast agents are available for all major imaging techniques 
and can provide better visualization of areas of interest
3
.  Some contrast agents are 
harmless, like microbubbles in ultrasound and the use of indocyanine green in optical 
imaging.  Microbubbles are simply micron sized bubbles of gas surrounded by a lipid or 
protein shell which have a high echogenicity.  When injected, they provide areas of high 
signal which can be used to investigate blood flow, lesions, and perfusion in organs
16, 37, 
38
.  This can be seen in figure 2, showing a renal carcinoma as seen with and without the 
use of microbubbles during imaging
37
.  With contrast agent, the signal to noise ratio is 
  12 
clearly increased.   Indocyanine green (ICG) is a cyanine based fluorescent dye used in 
optical imaging.  It has been the industry standard fluorescent dye for more than 50 years 
with little toxicity reported
21
.  In figure 5 a rat has been imaged using ICG to map 
different organs based on its progress through the body 
39
. 
 
 
.  
Figure 2: Ultrasound image of a renal carcinoma (denoted with white arrow), with (left) 
and without (right) the use of microbubbles as a contrast agent
38
. 
 
 
Some contrast agents are not as benign.  CT scans with and without the use of contrast 
agent can be seen in figure 3, the difference in visualization ability is undeniable
40
.  
However, iodine based agents can cause severe allergic reactions as well as contrast 
induce neuropathy
19
.  This can cause kidney damage and failure.  Although rare, it is a 
problem for a high risk population consisting of individuals with diabetes and the elderly, 
both growing in the United States
20
.  Figure 4 shows a cranial MRI with and without 
imaging agent, an arrow is used to indicate the site of a lesion
41
.  Although helpful, MRI 
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gadolinium contrast agents also cause kidney problems.  This type of agent relies on 
strong chelation of the gadolinium ion, which when unbound is highly toxic
17
.  
Nephrogenic systemic fibrosis is a disease attributed to the leaching of these ions.  This 
disease causes hardening of the skin, which can spread to the heart and lungs causing 
failure and death
15, 17
.  It can also cause kidney failure and minor side effects such as 
headache and nausea.  The elderly and the diabetic population are again at a greater risk 
for the more serious side effects.  Although serious problems are rare, they are not 
unheard of and with the increase in use are likely to become more common
17, 34
. 
 
 
 
Figure 3: A CT scan of the brain without (left) and with (right) contrast agent
40
. 
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Figure 4: A MRI image of a nodule in the temporal lobe, as seen with (bottom) denoted 
with a white arrow, and without (top) contrast agent
41
. 
 
 
 Targeting  
 
 
Optical imaging is of great interest due to its ability to obtain high resolution 
visualization of deep tissues.  The combination of resolution with safety makes it a more 
viable source of visualization for a wide range of uses.  Figure 5 shows a composite of 9 
optical images, mapping internal organs based on the rate indocyanine green (ICG) 
passes through the body
39
.  Fluorescent dyes provide even higher visual contrast, which 
enables better differentiation of different species present
4, 5
.  Although ICG has been used 
for over 50 years, there is an interest in new specialized dyes which can be targeted to 
label specific molecular species.  Targeting facilitates the accumulation of dye at a 
particular site of interest, which can allow for better imaging at a reduced concentration, 
in turn reducing toxicity risks
2, 4, 30
. 
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Figure 5: Composite of 9 optical images of a rat using ICG to map different internal 
organs non-invasively
39
. 
 
 
By targeting biological molecules which are influenced by the presence of disease, such 
as the response of an antibody or protein at the site of abnormality, a more distinct picture 
of the infected area can be established.  This can be very helpful when monitoring 
treatment.  Targeting is the binding of a probe or marker with a biological species or 
synthetic polymer.  Small molecules are often used in an attempt to suppress potential 
immune responses
2, 4, 42, 43
.  In this model system, we will focus on the targeting of lysine 
containing species such as proteins
28
.   
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Proteins are commonly labeled using n-hydroxysuccinimide (NHS) derivatives as cross 
linkers.  Derivatives containing the NHS moiety are very reactive with primary amides 
found in lysine.  This allows for the specific labeling of species which contain accessible 
lysine binding sites
28
.  Tumors often overexpress proteins on their surface, targeting of 
such proteins can provide an accumulation of contrast agent at the site providing a clear 
outline of disease
4, 44
. 
 
 
Design of Molecular Probe 
 
 
There are many aspects which need to be considered in the design of a new molecular 
probe.  For optical imaging, spectral characteristics are extremely important.  For the 
probe to be optically active it must contain a chromophore.  To be targeted it must 
contain a bioactive moiety or the means for attachment, such as a functional group.  It 
should be both photo and chemically stable, have strong spectral characteristics to 
provide a high signal to noise ratio, and have desired pharmacological attributes such as a 
low toxicity and aqueous solubility
5, 45
  
 
Probes must react with specific biological molecules
43
.  Usually binding is limited to one 
dye per binding site with potential for a number of sites
46
.  They should be selective, 
designed with moieties able to conjugate with only the species of interest
47
.  Ideally these 
probes should be nontoxic with no mutagenic or carcinogenic effects and be eliminated 
from the body in a reasonable timeframe.  They should also strongly absorb and emit at 
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different wavelengths within the optical window
48
.  All characteristics must be addressed 
for a probe to be a feasible candidate for in vivo optical imaging
49
.     
 
 
Spectral Properties 
 
 
A species spectral characteristics describe the way it interacts with light.  This becomes 
extremely important for any dye considered in optical imaging.  The most important 
characteristics are the absorbance and emission wavelengths, the molar absorptivity, the 
Stokes shift, and the quantum yield.  The absorbance intensity is the extent light energy is 
taken in or absorbed by a particular species; the emission is the release of that energy in 
the form of light at the same or at a different wavelength.  Different chromophores absorb 
and emit at different wavelengths depending on the energy spacing between the highest 
occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO).  
The difference between the absorption and emission wavelengths is the Stokes shift
50
.  A 
large Stokes shift is desirable for several reasons.  If a dye exhibits a large Stokes shift 
then you can excite the sample at one wavelength and use filters and a detector to capture 
the emission at a different wavelength.  A large shift limits the probability of reabsorption 
which weakens the signal
2
.   
 
The molar absorptivity is the absorbance intensity per unit molar volume.  It can be 
thought of as a measure of the brightness of the dye.  High molar absorptivity allows for 
strong signals at lower concentrations, which decreases problems associated with toxicity 
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as well as aggregation.  The quantum yield (QY) is an important factor in achieving a 
high signal to noise ratio
50
. 
 
Quantum yield is a measure of the fluorescence efficiency.  It can be thought of as the 
ratio of the number of absorbed to emitted photons.  The higher the quantum yield the 
higher the percentage of absorbed photon energy is released as light, allowing for 
stronger signals at lower concentrations.  Quantum yield can be reported in two ways:  
the absolute quantum yield, which requires very precise information about the exact 
number of photons received by the samples, and the relative method which calculates the 
quantum yield of an unknown based on that of a well characterized standard.  Reporting 
the exact method of determination is critical as the quantum yield can change 
considerably with the surround environment, bound or unbound.  It may drastically shift 
with each structural change as well as with differences in solvent, and therefore should be 
calculated for all intended environments.  We will be determining quantum yield based 
on the relative method using water as a solvent.  The relative method is preferred in this 
case as it accounts for solvent differences between the unknown and the standard by 
incorporation of the ratio of refractive indexes.  Differences in reported relative quantum 
yield are common, distortions in measurements can occur with errors in the absorbance 
intensity and if fluorescence varies nonlinearly with concentration.  Absorbance 
intensities should be no higher than 0.05 to minimize this error
51
.  Other sources of error 
include filter effects, bad dissolution or variations in concentration, the presence of 
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gaseous oxygen present in the sample, impurities, and instabilities all of which can cause 
false intensities at either higher or lower than true values
51, 52
.      
 
The absorption and emission wavelength are extremely important for biological 
fluorescent dyes because there is such high scatter and absorption from prevalent species 
such as water, hemoglobin, and melanin
53
.  Scatter cause by biological species is 
Rayleigh type scattering which is proportional to the inverse of the wavelength to the 
fourth power.  This means that at longer wavelengths there is less scatter allowing for a 
lower background signal
54
.   
 
Although longer wavelengths give less scatter, beyond 1000nm problems with absorption 
are seen.  There is an optical window when absorption is minimized and signal to 
background ratios can be optimized between 600-1000nm.  Outside this range, problems 
with scatter and/or absorbance limit penetration up to a few millimeters at best.  Within 
this range, however, depths up to several centimeters can be realized.  Also, because 
optical imaging technology can be adapted to fit endoscopic means, even deeper 
penetration depths can be obtained.  This can help ease imaging problems for the obese 
population
2, 5, 7
. 
 
 
Cyanine 
 
 
Cyanine dyes, such as ICG, have been investigated for their use in various applications of 
optical imaging.  Cyanines are known to absorb and emit at longer wavelengths in part to 
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a structural aspect known as the methanine bridge.  This conjugated bridging section can 
produce a red shift of 80-100nm to the absorption wavelength of the chromophore with 
each double bonded carbon
46
.  Cyanine dyes are categorized by the number of carbons in 
this bridging section.  Cyanine 3, 5, and 7 (Cy3, Cy5, and Cy7) have increasing 
absorbance and emission wavelengths
23
.  Cy3 dyes typically absorb around 500-600nm 
(seen in figure 6), Cy5 dyes absorb around 600-700 (seen in figure 7), and Cy7 dyes 
absorb around 700-800 (seen in figure 8).  This broad nomenclature applies regardless of 
heterocyclic nuclei and moieties present which also influence the resulting wavelength.  
Although Cy7 dyes absorb further into the optical window, this comes with an increase in 
the reactivity of this methanine bridge
55, 56
.  Increases in reactivity cause a decrease in 
stability which may be both photo and chemical in nature.  Several carbocynanine 
derivatives have been applied in bioconjugation and targeting of species and show high 
biocompatibility.  Commercial cyanines are available for the labeling of biological 
species such as DNA
15,55,57,1, 58 
.   
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Figure 6: Cyanine 3, or Cy3, derivatives contain three carbons in the methanine bridge 
and usually absorb and emits between 500-600nm. 
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Figure 7: Cyanine 5, or Cy5, derivatives contain five carbons in the methanine bridge and 
usually absorb between 600-700nm. 
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Figure 8: Indocyanine Green (ICG), a Cy7 type dye which has been used in the optical 
imaging field for over 50 years. 
 
 
Cross linkers 
 
 
Cross linkers are a group of species known to provide a source of binding between two 
otherwise unbindable species.  We are particularly interested in n-hydroxysuccinimide 
(NHS) a commonly used cross linker which reacts readily with primary amides.  The 
structure of NHS can be seen in figure 9.  Lysine, an amino acid, is known to contain 
these primary amides.  Incorporation of an NHS moiety is a common method which 
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allows a dye to label proteins.  This is generally done with the ester variety, but in this 
case NHS was modified to contain an azidopropane derivative without the ester 
functionality
28, 29
.  
 
 
N
O O
OH
 
Figure 9: N-hydroxysuccinimide (NHS) is a cross linker which is commonly used in the 
labeling of proteins or species containing primary amides. 
 
 
Proposed Design 
 
 
The dye we are interested in is an asymmetric carbocyanine dye introduced by Shao, et 
al.,
1
.  This dye presents several advantages such as a strong absorption and emission 
within the optical window, a reasonable quantum yield, and a low toxicity seen in 
previous testing in vivo.  This dye has also been shown to incorporate three different 
functional groups, two of which are known to participate in click type reactions
1
.   
 
Alkyne and azide functionalities in the presences of copper (II) sulfate and sodium 
ascorbate are known to participate in a Hüisgen cycloaddition resulting in the formation 
of a stable 1, 2, 3-triazole.  Click reactions are known for their high product specific 
yields using benign solvents at low temperatures.  They are often utilized for the 
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synthesis of large, complicated structures through the assembly of smaller modular units.  
Because of the high thermodynamic driving force, these reactions proceed quickly and 
predictably
27, 59
.  By incorporating this functionality in the final dye, a means for 
attachment to a linker could be realized.  An azidopropane NHS species which is targeted 
to a specific molecular species was chosen to facilitate the targeting of the cyanine dye of 
interest.  When assembled, this dye-linker pair will act as a molecular probe, targeted 
towards proteins.  In this model system, the protein is BSA, if it can be determined that 
binding does indeed occur, the work can be applied to specific proteins known to be 
overexpressed during tumor growth.  The final proposed probe can be seen in figure 8. 
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Figure 10: Chemical structure of synthesized molecular probe consisting of pentamethine 
carbocynanine backbone 
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CHAPTER THREE 
 
EXPERIMENTAL 
 
 
Instrumentation and Reagent Information 
 
 
Dimethyl formaldehyde (DMF), pyridine, tetrahydrofuran (THF), acetic acid, 
isopropanol, chloroform, dichloromethane (DCM), dimethylsulfoxide (DMSO) was 
received from Acros.  Potassium hydroxide, copper (II) sulfate, and sodium ascorbate 
were obtained from Aldrich.  3-methyl-2butanone and iodoethane were obtained from 
Alfa Aesar.  Bovine serum albumin (BSA) was obtained from Baker.  Micro dialysis float 
units, hydrochloric acid, and sodium sulfate  were obtained by  Fisher Scientific,  
Potassium carbonate was obtained from Fluka, phosphate buffer solution (PBS) was 
obtained from Thermo Scientific,  N-hydroxysuccinimide was obtained from TCI, and 
methanol, diethyl ether and acetone were obtained from VWR.  Methyl 5, 5 
dimethoxyvalerate, hydrazine benzene, and (Azidopropane) were prepared previously by 
Yurii Bandera.  
 
Tetrahydrofurane (THF) was purified with an IT PureSolv solvent purification system.  
Rotary evaporation was done using a Büchi rotovapor R-200.    All masses were recorded 
using an Ohaus Explorer analytical balance.  Centrifuge was done using a Beckman J2-21 
high speed refrigerated centrifuge. All 
1
H and 
13
C NMR were taken on a Joel ECX-300 
relative to tetramethylsilane (TMS), the internal standard.  All absorbance was done on a 
Perkin Elmer Lambda 850 spectrometer.    Fluorescence intensities were recorded using a 
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Horiba Jobin-Yvon microHR spectrometer coupled to a synapse charge coupled device 
(CCD).   
 
 
Preparation of Dye 
 
 
All dye synthesis was according to Shao, et al., and was carried out with minor changes 
in the initial preparation of the dianil intermediate
1
.   A final reaction scheme between 
two synthesized intermediates is seen in figure 10. 
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Figure 11: Final dye synthetic route 
 
 
Synthesis and Hydrolysis of 5-(Phenlamino)-4-(phenylimino) methyl)- 
4-pentenoic Acid Derivative  
 
The general scheme for the first intermediate can be seen in figure 12. 
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Figure 12: Synthetic route for the alkyne intermediate. 
 
 
A 1:3:1.5:3 molar ratio of methyl 5, 5 dimethoxyvalerate, dimethyl formaldehyde (DMF), 
phosphoryl chloride, and 3-ethynylaniline was used, which was a deviation from the 
procedure found in Shao, et al.,
1
.  DMF and phosphoryl chloride were combined with 
stirring and a heat gun was used to raise the temperature to 70°C, turning the solution 
from colorless to red.  After cooling, methyl 5, 5 dimethoxyvalerate was added drop wise 
and the reaction was stirred for 6 hours at room temperature.  3-ethynylaniline, which 
provided the alkyne functionality, was dissolved in methanol and added to the reaction 
flask, which was then stirred at room temperature overnight.  A crude yellow product was 
precipitated in water and dried.  This ester intermediate was then dissolved in THF before 
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the addition of an aqueous sodium chloride solution.  This was then acidified with 
hydrochloric acid and a crude product was precipitated in excess THF.  The solvent was 
removed via rotary evaporation resulting in a yellow product which was filtered and used 
without further purification.  
 
Product was verified by 
1
H NMR (301 MHz, DMSO-d6) δ ppm 8.92 (s, 2H), 7.41 (s, 1H), 
7.37 (d, 2H, J=7.2Hz), 7.34 (d, 2H. J=8.0Hz), 7.2 (d, 2H, J=6.8Hz), 4.24 (s, 2H), 2.79 (t, 
2H, J=7.5Hz), 2.44 (t, 2H, J=7.8Hz).  Yield was comparable to literature at about 23%. 
  
 
Preparation of potassium 2, 3, 3-trimethyl-3H-indole-5-sulfonate 
 
A reaction scheme for this indolinium salt intermediate is shown in figure 13. 
 
A 1:2 molar ratio of hydrazinobenzene sulfonic acid and 3-methyl-2-butanone were 
dissolved in a 4:1 volumetric ratio of acetic acid and acetic anhydride.  The solution was 
refluxed between 3-5 hours, sometimes overnight before the solvent was removed via 
rotary evaporation.  The resulting residue was dissolved in methanol and a saturated 
solution of potassium hydroxide in isopropanol was added.  This was allowed to reflux 
for 10 minutes before it was cooled to room temperature.  After cooling crude product 
was precipitated in excess diethyl ether, filtered, and dried.  A 1:3 molar ratio of this 
potassium intermediate and iodoethane were combined in acetonitrile and refluxed 
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overnight.  After cooling, the resulting violet solid was filtered and washed with acetone 
before being dried.   
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Figure 13: Synthetic route for the preparation of the indolinium salt intermediate, a 
reagent in the final dye 
 
 
The product was verified by 
1
H 
1
H NMR (301 MHz, DMSO-d6) δ ppm: 7.63 (d, 1H, 
J=1.5Hz, H-4), 7.56 (dd, 1H, J=7.9, 1.5Hz, H-6), 7.34 (d, 1H, J=7.9Hz, H-7), 2.21 (s, 
3H), 1.24 (s, 6H).  Yield 58%. 
 
 
Preparation of final dye 
 
The dianil intermediate was dissolved in a15:5:1 volumetric ratio of acetic anhydride, 
acetic acid, and pyridine, which was heated to 100˚C, and stirred for 2 hours before the 
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addition of the indolinium salt intermediate.  This reaction was brought back up to 
temperature and stirred for an additional hour.  The resulting solution was cooled and 
added drop wise to excess diethyl ether to precipitate a crude product.  The precipitate 
was separated by centrifuge then purified using silica gel column chromatography with a 
1:3 ratio of methanol to chloroform.  This resulted in 85 grams of dark blue product, 
about 70% yield.   
 
Verification was done via 
1
H NMR (301 MHz, DMSO-d6) δ ppm 10.08 (s, 1H), 8.19 (d, 
2H, J=14.2Hz), 7.82 (s, 2H), 7.79 (s, 1H), 7.64 (d, 2H, J=8.4Hz), 7.48 (d, 1H, J=8.8Hz), 
7.33 (d, 2H, J=8.4Hz), 7.25 (t, 1H, J=7.9Hz), 7.07 (d, 1H, J=7.6Hz), 6.38 (d, 2H, 
J=14.2Hz), 4.21-4.18 (m, 4H), 4.05 (s, 1H), 2.98 (t, 2H, J=6.8), 2.54 (t, 2H, J=6.8Hz), 
1.68 (s, 12H), 1.14 (t, 6H, J=7.3Hz).  The absorption and emission of the free dye were 
investigated in water.  This can be seen in figure 14.   
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Figure 14: The absorbance (•) and emission (o) at 642nm excitation of the unbound dye 
in water. 
 
 
Preparation of Linker 
 
 
Preparation of 1-(3-azidopropoxy) pyrrolidine-2, 5-dione 
 
A general scheme for the synthesis of the NHS derivative is shown in figure 15.   
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Figure 15: Synthesis of the cross linker (1-(3-azidopropyl) pyrrolidine-2, 5-dione) 
 
 
A 1:1 molar ratio of 1azido-3-iodopropane and NHS was used.  Using potassium 
carbonate as a buffer, azidopropane was added to DMF at 80°C.  This solution was 
allowed to stir for 10 minutes before the addition of NHS.  After this addition the reaction 
was left at 80°with stirring for 4 hours.  After cooling, a crude product was precipitated 
by drop wise addition to diethyl ether.  This product was then washed with deionized 
water and acidified with hydrochloric acid.  The water layer was collected and the 
product was extracted with dichloromethane (DCM), which was then dried using sodium 
sulfate.  After filtering, the DCM was removed via rotary evaporation.  Remaining 
solvent was removed by the application of an air stream overnight.  The final product was 
verified by 
1
H NMR (301 MHz, DMSO-d6) δ ppm 1.81 (t, J=6.47 Hz, 2 H) 2.57 (s, 4 H) 
3.49 (t, J=6.74 Hz, 1 H) 4.02 (t, J=6.19 Hz, 2 H). Yield 53% 
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This compound was thought to be unstable in water due to the reactivity of the NHS 
moiety.  This was testing by immersing the oil in an aqueous environment for 1 week 
before extraction again with DCM, drying with sodium sulfate, filtering, and removing 
solvent.  The remaining oil was verified by 
1
H NMR and showed no sign of degradation.   
 
 
Click Reaction 
 
 
A copper catalyzed click type reaction was carried out in methanol, joining the azide 
functionality of the NHS derivative with the alkyne functionality of the dye.  The general 
scheme of this Hüisgen 1, 3 dipolar cycloaddition can be seen in figure 16 and the final 
proposed probe can be seen in Figure 8.   
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Figure 16: The Hüisgen cycloaddition between an alkyne and azide. 
  35 
 
 
1:1:2:10 molar ratio of dye, NHS derivative, copper (II) sulfate, and sodium ascorbate 
was used and the reaction was carried out in methanol.  The dye, NHS derivative, and 
sodium ascorbate were combined in methanol with stirring at room temperature.  After a 
10 minute nitrogen purge, copper (II) sulfate was added and the reaction flask was sealed 
and allowed to stir for 2 days.  After this time, a small sample was collected and run on a 
TLC plate in a 3:1 ratio of DCM to methanol.  This ratio was used to separate products in 
silica gel column.  The remaining product was cleared from the column using water.  
Two solutions were collected. The second dark blue product was verified to contain the 1, 
2, 3 triazole by 
1
H NMR.  (301 MHz, DMSO-d6)  ppm 10.08 (s, 1H), 8.19 (d, 2H, 
J=14.2Hz),7.83 (s, 1 H) 7.82 (s, 2H), 7.79 (s, 1H), 7.64 (d, 2H, J=8.4Hz), 7.48 (d, 1H, 
J=8.8Hz), 7.33 (d, 2H, J=8.4Hz), 7.25 (t, 1H, J=7.9Hz), 7.07 (d, 1H, J=7.6Hz), 6.38 (d, 
2H, J=14.2Hz), 4.83-4.81 (m, 4H), 2.98 (t, 2H, J=6.8), 2.54 (t, 2H, J=6.8Hz), 1.68 (s, 
12H), 1.14 (t, 6H, J=7.3Hz). 
 
 
Bioconjugation 
 
 
Conjugation was carried out using a procedure outlined by Thermo Fisher Scientific
28
. 
A 14:1 molar ratio of probe to BSA was used.  The molecular probe was dissolved in 
DMSO (1mg/100µL DMSO) before its addition to BSA in phosphate buffer (10mg/mL) 
solution (PBS).  This solution was stirred at room temperature for 1 hour.  The product 
was then purified by dialysis against PBS under refrigeration for three days, changing the 
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solution twice daily.  It was determined the dialysis was complete when the final product 
no longer showed a loss in color.  The absorption and emission were tested in PBS, the 
spectra is shown in figure 17. 
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Figure 17: The absorbance (•) and emission (o) at 642nm excitation in PBS of the 
molecular probe when bound to BSA.   
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CHAPTER FOUR 
 
RESULTS AND DISCUSSION 
 
 
Synthesized Dye 
 
 
In the preparation of the Cy5 dye, there were few modifications from the original 
procedure presented by Shao, et al., mainly the preparation of the initial intermediate as 
noted
1
. 
 
This particular cyanine dye was comprised of a Cy5 scaffold with two identical 
monosulfonated indolinium moieties which provide excellent solubility in both methanol 
and water.  This dye was chosen for its respectable reported yield of around 65%, which 
matches the yield for our slightly modified synthesis
1
.  The desired alkyne functionality 
was introduced to the structure by the malonaldehyne dianil moiety.  Verification of the 
final dye species was done through spectral and structural characteristics.  NMR results 
show matching shifts for all major features and the absorption and emission were shown 
to be identical to literature, with maxima of 641 and 658nm respectively.  This is a 
moderate Stokes shift of about 16nm.  This shift is somewhat small for the probes 
intended purpose, but improvement may be an avenue of future study.   
 
The dye showed strong absorption in aqueous solutions at micro molar concentrations.  
The molar absorptivity, found by Beer’s law, equation 2, was around 144,000 L·M-1cm-1 
in water, which was lower than the reported value which was 240,000 M
-1
cm
-1
 in PBS.  
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This difference may be attributed to error in concentration due to impurities or changes in 
pH between deionized water and PBS
50
. 
 
 
 
 
Equation 1: Beer's law relates the absorbance intensity (A) with the molar absorptivity 
(ε), path length (b=1cm), and concentration (c). 
 
 
The quantum yield (Φ) was found to be 0.20 (or 20%) in water relative to zinc 
phthalocyanine (ZnPc) in DMF (Φ=18%), matching literature.  In order to calculate the 
relative quantum yield, the absorbance and emission at 642nm data for a known standard, 
ZnPc, and the unknown sample were collected
60
.  The absorbance intensity accounts for 
the perceived number of photons absorbed and the area under the emission curve 
provides the number of emitted photons.  The advantage of the relative method is that the 
use of different solvents can be accounted for by incorporation of their refractive indices.  
It is important to choose a standard with similar spectral properties to the unknown, 
trying to match the absorbance and emission maximums if possible.  Zinc phthalocyanine 
(ZnPc) was used as a standard because it is well characterized in several solvents and has 
absorption and emission maxima at 670 and 675nm respectively
52, 60
.   
 
Distortions in this type of measurement can occur from error in the absorption intensity 
as well as if the fluorescence changes nonlinearly with concentration.  The concentrations 
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of the samples should be such that the absorbance intensities are no higher than 0.05 
absorbance units (ABU).  When concentrations are maintained at and under 
recommended levels, this change can be assumed as linear.  Low concentrations also help 
mitigate any filter effects seen which lower the perceived emission
52
.   
 
The relative method uses the ratio of the integrated fluorescence intensities, which 
corresponds to the ratio of known quantum yield to unknown.  Using a well-defined 
standard with a known quantum yield, the unknown quantum yield is easily found using 
the equation 2.  There are a few assumptions made during this procedure.  It is assumed 
that both samples are exposed to the same number of photons at the same excitation 
wavelength.  In order to use this method, first the absorbance and fluorescence spectra of 
the unknown and standard samples are collected at a minimum of three different 
concentrations.  Also a solvent background is collected and taken into account.  The 
integrated fluorescence is then plotted against the absorbance, maintaining an intercept of 
one.  The slope of this plot is then used to calculate the quantum yield
52
.   
 
 
 
 
Equation 2:  Relative quantum yield of an unknown (Φx) can be established through this 
equation using a well-established standard, where Grad is the slope of the integrated 
fluorescence intensity vs. the absorbance intensity and η is the refractive index. 
 
 
Cross linker 
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The linker was prepared through a simple nucleophillic substitution between the halogen 
on the azidopropane species and the hydroxide group present in NHS.  This reaction is 
commonly known as a Williamson ether synthesis and was done using simple reaction 
conditions in a carbonate buffer
61
.  This gave a good efficiency of upwards of 60% 
yields.  The yellow oil obtained was initially thought to be reactive with water, which 
would be problematic in the application of the probe, however testing in water verified 
that after a week no degradation of the initial compound was seen.   
 
 
Assembly of Probe 
 
 
The reaction to assemble the probe was a common click reaction between azide and 
alkyne functionalities.  As the final product was run through a column, it cannot truly be 
categorized as a click type reaction because click type reactions are characterized by 
simple methods of purification such as recrystallization or filtration
27
.  However it is 
thought that this purification technique was not necessary.  A way to remove excess 
copper (II) sulfate and sodium ascorbate needs to be determined.  Usually washing with 
water is sufficient, however as the product is extremely water soluble, this was 
ineffective.  It was thought that any unreacted materials would be cleaned through the 
final binding with the protein and subsequent dialysis.  This prevents us from establishing 
an accurate yield, as unreacted species may still be present in the product solution, even 
after separation through the column.  Establishing an effective means of product isolation 
would be of great interest to be able to report a reasonable yield.  Due to the nature of the 
reaction and evidence of the formation of a 1, 2, 3 triazole shown in 
1
H NMR binding did 
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occur.  The hydrogen in the triazole ring was evident by a singlet 7.83 ppm and the signal 
at 2.75 ppm had a lower integration due to the disappearance of alkyne functionality.  
Running the reaction at a slightly increased temperature as well as an increased time may 
help reduce the amount of unreacted species. 
 
 
Conjugation to a Protein 
 
 
BSA was used as a model protein system to determine if the probe was sufficient for its 
intended application.  This was done using common protein labeling techniques presented 
by Fisher Scientific.  Dialysis was used on a micro scale to purify a small portion of the 
reaction solution.  A mini dialysis tube was first soaked in PBS to remove any glycerin 
present.  The mini tube had a high molecular weight cut off to ensure that any unreacted 
materials other than protein would be eliminated through osmosis.  The purification was 
determined to be complete when no further loss of color was seen, at which point the 
PBS was changed one more time as a precaution.  Successful binding was assumed 
through visual inspection, as the reaming BSA solution was blue in color, as well as 
through spectral methods.  The absorbance and emission wavelength were identical to 
that of the free dye, with a slight loss in emission intensity seen between figure 14 and 
figure 17.  
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CHAPTER FIVE  
 
CONCLUSION 
 
 
The cyanine derivative with alkyne functionality was successfully synthesized with slight 
modification to the method outlined in Shao, et al.,
1
.  It was shown that the NHS could be 
modified to contain an azidopropane moiety which allowed its participation in click type 
cycloadditions between azide and alkyne moieties.  This click type reaction bound the 
dye successfully to the NHS derivative, allowing for lysine containing species to be 
labeled or targeted by the probe.  BSA was used as a model system to determine if the 
NHS moiety would bind with protein without the presence of an NHS ester commonly 
used for protein labeling.  After 3 days of dialysis, it was determined that binding did 
occur by visual inspection and spectral properties.  Free dye and impurities smaller than 
10,000 grams/mole were able to pass through the membrane while dye bound to protein 
remained.   
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CHAPTER SIX 
 
FUTURE WORK 
 
 
Using a model system, binding does appear to occur.  However, future testing should be 
done.  Binding should be verified through SDS-Page testing, a protein separation 
technique which would allow for the bound dye to be distinguished through a photo 
reactive band at the characteristic site of the protein.  In addition to this, a more complete 
spectral analysis should be done, including the quantum yield and molar absorptivity.  As 
this is only a model system, the molecular probe should also be tested against other 
proteins, such as human serum albumin, as well as specific proteins which are 
overexpressed on the surface of tumors.  
 
Another avenue to pursue would be the synthesis of an ester type NHS derivative, which 
may be more reactive towards primary amides found in proteins.  This reactivity would 
also be increased in water and may cause the probe to be unstable in aqueous solutions
29
.   
 
Different means of binding could also be attempted through the direct modification of the 
dianil intermediate of the initial dye.  By incorporating an NHS ester or maleimide on the 
site where the alkyne is attached a condensed method of targeting may be accomplished.  
This modification may come with modified spectral characteristics which should be 
considered and investigated.   
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One area that would be of great interest is the incorporation of a Förster resonance energy 
transfer (FRET) pair to increase the effective Stokes shift.  A FRET paired dye absorbs at 
the emission wavelength of a mate, providing a means for a second absorption and 
emission phenomenon.   This mechanism provides a means for longer emission 
wavelengths and an increase in the perceived Stokes shift, providing a better signal to 
noise ratio at increased depths.  Although this seems easy to accomplish, the 
chromophores must be within 10nm of each other for FRET to occur.  The determination 
and attachment of a FRET counter chromophore would present an entirely new project
62
.   
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